Cargando…
Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?
The current use of combined antiretroviral therapy (cART) is leading to a significant decrease in deaths and comorbidities associated with human immunodeficiency virus type 1 (HIV-1) infection. Nonetheless, none of these therapies can extinguish the virus from the long-lived cellular reservoir, incl...
Autores principales: | Borrajo López, Ana, Penedo, Maria Aránzazu, Rivera-Baltanas, Tania, Pérez-Rodríguez, Daniel, Alonso-Crespo, David, Fernández-Pereira, Carlos, Olivares, José Manuel, Agís-Balboa, Roberto Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389599/ https://www.ncbi.nlm.nih.gov/pubmed/34440127 http://dx.doi.org/10.3390/biomedicines9080925 |
Ejemplares similares
-
Important role of microglia in HIV-1 associated neurocognitive disorders and the molecular pathways implicated in its pathogenesis
por: Borrajo, A., et al.
Publicado: (2020) -
Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients
por: Fernández-Pereira, Carlos, et al.
Publicado: (2022) -
Genomic Factors and Therapeutic Approaches in HIV-Associated Neurocognitive Disorders: A Comprehensive Review
por: Borrajo, Ana, et al.
Publicado: (2023) -
Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder
por: Fernández-Pereira, Carlos, et al.
Publicado: (2023) -
MiRNA Differences Related to Treatment-Resistant Schizophrenia
por: Pérez-Rodríguez, Daniel, et al.
Publicado: (2023)